Stratec SE is a German-based European stock corporation (SE) specializing in the design, development, and manufacture of fully automated analyzer systems for clinical diagnostics and biotechnology app... Stratec SE is a German-based European stock corporation (SE) specializing in the design, development, and manufacture of fully automated analyzer systems for clinical diagnostics and biotechnology applications. Founded in 1979 in Birkenfeld, the company has evolved into a global leader in laboratory automation, covering the entire value chain from specification and engineering to production, quality assurance, and supply of complex consumables and integrated software solutions. As an original equipment manufacturer (OEM), Stratec SE partners with major diagnostic firms such as DiaSorin, Abbott, Siemens, Bio-Rad, and Hologic, enabling them to deliver comprehensive system solutions—including proprietary reagents—to laboratories, blood banks, and research institutes worldwide. Notable features include patented technologies for sample preparation, middleware software, and smart consumables for medical applications, bolstered by strategic acquisitions like Diatron in 2016 for hematology analyzers, Sony DADC Biosciences (now STRATEC Consumables) for polymer-based products, and Natech Plastics in 2023 to expand U.S. presence. With over 1,300 employees across sites in Germany, Switzerland, the USA, Romania, Hungary, Austria, China, and India, Stratec SE plays a pivotal role in advancing in-vitro diagnostics and life sciences through innovation and reliability.
We have not yet reviewed Stratec's disclosures for Group Entities data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.